Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Apricus announces publication of NexACT technology data in Pharmaceutics Journal

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Spectrum's FUSILEV sNDA accepted by FDA for review

Spectrum's FUSILEV sNDA accepted by FDA for review

Whooping cough outbreak in Oklahoma

Whooping cough outbreak in Oklahoma

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

BioAlliance presents AMEP preclinical, phase I clinical results for melanoma at Electrochemotherapy Meeting

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial

International businessman donates $50,000 for SCCO cancer study

International businessman donates $50,000 for SCCO cancer study

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

MK-4827 drug candidate shows promising anti-tumour activity in first human trial

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

A.P. Pharma third quarter net loss increases to $1.7 million

A.P. Pharma third quarter net loss increases to $1.7 million

Santarus announces commercial U.S. launch of CYCLOSET for type 2 diabetes mellitus

Santarus announces commercial U.S. launch of CYCLOSET for type 2 diabetes mellitus

New 'magic bullet' can eradicate side effects of drug used to treat cystinosis

New 'magic bullet' can eradicate side effects of drug used to treat cystinosis

MonoSol Rx granted U.S. patent for PharmFilm and production technologies

MonoSol Rx granted U.S. patent for PharmFilm and production technologies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.